A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Emtricitabine Impurity 32 - Request Quote

Picture of Emtricitabine Impurity 32

Emtricitabine Impurity 32

SZ CAT No:SZ-E010075
CAS No
NA
Mol.F.
C19H27FN2O4S
Mol.Wt.
398.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Emtricitabine Impurity 32 is chemically (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-((3-fluoro-6-hydroxypyridin-2-yl)amino)-1,3-oxathiolane-2-carboxylate. Emtricitabine Impurity 32 is supplied with detailed characterization data compliant with regulatory guideline. Emtricitabine Impurity 32 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Emtricitabine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Emtricitabine Impurity 32

Purchase Emtricitabine Impurity 32

Emtricitabine Impurity 32 suppliers

Emtricitabine Impurity 32 manufacturers

Emtricitabine Impurity 32 price

Order Emtricitabine Impurity 32

Enquire Emtricitabine Impurity 32

Emtricitabine Impurity 32 cost

Emtricitabine Impurity 32 Supplier

Emtricitabine Impurity 32 Distributor

Emtricitabine Impurity 32 for Method Validation

Emtricitabine Reference Standard

Emtricitabine Impurity 32 for ANDA Filing

Emtricitabine Impurity 32 for Forced Degradation Studies

Emtricitabine Impurity 32 Identification Standards

Emtricitabine Impurity 32 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,